eNeura, Inc. Announces Series D Financing

Investment to fund commercialization of eNeura's sTMS mini for treatment and prevention of migraine BALTIMORE, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- eNeura, Inc., a privately held medical technology company developing non-invasive, ... Devices, Neurology, Venture Capital eNeura Inc, mini neuromodulation, SpringTMS, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news